本可行性研究的主要目的是使用順序多重評估隨機對照試驗（ SMART ）設計，評估適應性階梯式護理幹預措施在改善中國輕度至中度睡眠障礙癌症患者睡眠質量方面的可行性和可接受性，以及潛在的臨床意義。
適應症：Neoplasm、Sleep Disturbance
收案條件
納入條件
- Cantonese- or Mandarin-speaking Chinese patients diagnosed with curable breast, colorectal, or gynaecological cancer
- Completed treatment (except endocrine therapy) within two years
- Presenting with Pittsburgh Sleep Quality Index (PSQI) score of 6 to 11 indicating mild-to-moderate sleep disturbance
排除條件
- Diagnosis of metastatic cancer
- Current diagnosis of psychiatric disorder
- Current diagnosis of another sleep disorder,
- Have received psychological treatment specifically for sleep disturbance
收案條件維持 ClinicalTrials.gov 原始英文登錄資料，實際收案資格以研究團隊的正式評估與受試者同意書為準。資料來源：ClinicalTrials.gov，每兩週自動更新，最後同步：2026年10月8日。